Exenterations 60 Years after first description; Results of a survey among US and German gynecologic oncology centers

Simone Marnitz, Sean Christopher Dowdy, Malgorzata Lanowska, Achim Schneider, Karl Podratz, Christhardt Köhler

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Objective: Sixty years after exenterative surgery was introduced into gynecologic oncology, the indications and contraindications, techniques, and adjuvant therapies after exenteration are controversially discussed between gynecologic oncologists. Methods: To evaluate the current patterns of care, a questionnaire with 48 items was sent to 40 Society of Gynecologic Oncologists member clinics with fellowship programs and all 38 German teaching hospitals for gynecologic oncology. Results: The mean number of exenterations performed during the last 5 years was comparable in both countries. Consistently, (central) recurrent cervical cancer or persistent tumor after chemoradiation is the main indication. Before exenteration, positron emission tomographyYcomputed tomography is mostly performed in the United States, whereas magnetic resonance imaging is the preferred imaging tool in Germany. Staging is more often done surgically in the United States (61%) compared with Germany (32%). None of the US institutions recommend an exenteration for patients with International Federation of Gynecology and Obstetrics stage IVA in contrast to 43% in Germany. In the case of fistula to the bladder and/or rectum, exenteration was recommended only by 29% and 61% in US and German clinics, respectively. In Germany, interdisciplinarity with general surgeons, urologists, plastic surgeons, and radio-oncologists is more common. There is consensus to apply adjuvant therapy after exenteration in patients with positive margins and/or positive lymph nodes. However, adjuvant therapy is more frequently recommended in Germany (93%) than in the United States (74%). Conclusions: Our data reflect considerable differences about indications and contraindications, preoperative staging, and adjuvant therapy for pelvic exenteration between Germany and the United States.

Original languageEnglish (US)
Pages (from-to)974-977
Number of pages4
JournalInternational Journal of Gynecological Cancer
Volume19
Issue number5
DOIs
StatePublished - Jul 2009

Fingerprint

Germany
Pelvic Exenteration
Therapeutics
Gynecology
Radio
Rectum
Teaching Hospitals
Uterine Cervical Neoplasms
Positron-Emission Tomography
Obstetrics
Fistula
Surveys and Questionnaires
Urinary Bladder
Lymph Nodes
Magnetic Resonance Imaging
Neoplasms
Surgeons
Oncologists

Keywords

  • Chemoradiation
  • Indication
  • Palliative exenteration
  • Pelvic exenteration
  • Primary cervical cancer
  • Recurrent cervical cancer
  • Survey

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynecology
  • Oncology

Cite this

Exenterations 60 Years after first description; Results of a survey among US and German gynecologic oncology centers. / Marnitz, Simone; Dowdy, Sean Christopher; Lanowska, Malgorzata; Schneider, Achim; Podratz, Karl; Köhler, Christhardt.

In: International Journal of Gynecological Cancer, Vol. 19, No. 5, 07.2009, p. 974-977.

Research output: Contribution to journalArticle

Marnitz, Simone ; Dowdy, Sean Christopher ; Lanowska, Malgorzata ; Schneider, Achim ; Podratz, Karl ; Köhler, Christhardt. / Exenterations 60 Years after first description; Results of a survey among US and German gynecologic oncology centers. In: International Journal of Gynecological Cancer. 2009 ; Vol. 19, No. 5. pp. 974-977.
@article{be8fa4f5d6b14fae9604e5be21bd5ef2,
title = "Exenterations 60 Years after first description; Results of a survey among US and German gynecologic oncology centers",
abstract = "Objective: Sixty years after exenterative surgery was introduced into gynecologic oncology, the indications and contraindications, techniques, and adjuvant therapies after exenteration are controversially discussed between gynecologic oncologists. Methods: To evaluate the current patterns of care, a questionnaire with 48 items was sent to 40 Society of Gynecologic Oncologists member clinics with fellowship programs and all 38 German teaching hospitals for gynecologic oncology. Results: The mean number of exenterations performed during the last 5 years was comparable in both countries. Consistently, (central) recurrent cervical cancer or persistent tumor after chemoradiation is the main indication. Before exenteration, positron emission tomographyYcomputed tomography is mostly performed in the United States, whereas magnetic resonance imaging is the preferred imaging tool in Germany. Staging is more often done surgically in the United States (61{\%}) compared with Germany (32{\%}). None of the US institutions recommend an exenteration for patients with International Federation of Gynecology and Obstetrics stage IVA in contrast to 43{\%} in Germany. In the case of fistula to the bladder and/or rectum, exenteration was recommended only by 29{\%} and 61{\%} in US and German clinics, respectively. In Germany, interdisciplinarity with general surgeons, urologists, plastic surgeons, and radio-oncologists is more common. There is consensus to apply adjuvant therapy after exenteration in patients with positive margins and/or positive lymph nodes. However, adjuvant therapy is more frequently recommended in Germany (93{\%}) than in the United States (74{\%}). Conclusions: Our data reflect considerable differences about indications and contraindications, preoperative staging, and adjuvant therapy for pelvic exenteration between Germany and the United States.",
keywords = "Chemoradiation, Indication, Palliative exenteration, Pelvic exenteration, Primary cervical cancer, Recurrent cervical cancer, Survey",
author = "Simone Marnitz and Dowdy, {Sean Christopher} and Malgorzata Lanowska and Achim Schneider and Karl Podratz and Christhardt K{\"o}hler",
year = "2009",
month = "7",
doi = "10.1111/IGC.0b013e3181a8351e",
language = "English (US)",
volume = "19",
pages = "974--977",
journal = "International Journal of Gynecological Cancer",
issn = "1048-891X",
publisher = "Wolters Kluwer Health",
number = "5",

}

TY - JOUR

T1 - Exenterations 60 Years after first description; Results of a survey among US and German gynecologic oncology centers

AU - Marnitz, Simone

AU - Dowdy, Sean Christopher

AU - Lanowska, Malgorzata

AU - Schneider, Achim

AU - Podratz, Karl

AU - Köhler, Christhardt

PY - 2009/7

Y1 - 2009/7

N2 - Objective: Sixty years after exenterative surgery was introduced into gynecologic oncology, the indications and contraindications, techniques, and adjuvant therapies after exenteration are controversially discussed between gynecologic oncologists. Methods: To evaluate the current patterns of care, a questionnaire with 48 items was sent to 40 Society of Gynecologic Oncologists member clinics with fellowship programs and all 38 German teaching hospitals for gynecologic oncology. Results: The mean number of exenterations performed during the last 5 years was comparable in both countries. Consistently, (central) recurrent cervical cancer or persistent tumor after chemoradiation is the main indication. Before exenteration, positron emission tomographyYcomputed tomography is mostly performed in the United States, whereas magnetic resonance imaging is the preferred imaging tool in Germany. Staging is more often done surgically in the United States (61%) compared with Germany (32%). None of the US institutions recommend an exenteration for patients with International Federation of Gynecology and Obstetrics stage IVA in contrast to 43% in Germany. In the case of fistula to the bladder and/or rectum, exenteration was recommended only by 29% and 61% in US and German clinics, respectively. In Germany, interdisciplinarity with general surgeons, urologists, plastic surgeons, and radio-oncologists is more common. There is consensus to apply adjuvant therapy after exenteration in patients with positive margins and/or positive lymph nodes. However, adjuvant therapy is more frequently recommended in Germany (93%) than in the United States (74%). Conclusions: Our data reflect considerable differences about indications and contraindications, preoperative staging, and adjuvant therapy for pelvic exenteration between Germany and the United States.

AB - Objective: Sixty years after exenterative surgery was introduced into gynecologic oncology, the indications and contraindications, techniques, and adjuvant therapies after exenteration are controversially discussed between gynecologic oncologists. Methods: To evaluate the current patterns of care, a questionnaire with 48 items was sent to 40 Society of Gynecologic Oncologists member clinics with fellowship programs and all 38 German teaching hospitals for gynecologic oncology. Results: The mean number of exenterations performed during the last 5 years was comparable in both countries. Consistently, (central) recurrent cervical cancer or persistent tumor after chemoradiation is the main indication. Before exenteration, positron emission tomographyYcomputed tomography is mostly performed in the United States, whereas magnetic resonance imaging is the preferred imaging tool in Germany. Staging is more often done surgically in the United States (61%) compared with Germany (32%). None of the US institutions recommend an exenteration for patients with International Federation of Gynecology and Obstetrics stage IVA in contrast to 43% in Germany. In the case of fistula to the bladder and/or rectum, exenteration was recommended only by 29% and 61% in US and German clinics, respectively. In Germany, interdisciplinarity with general surgeons, urologists, plastic surgeons, and radio-oncologists is more common. There is consensus to apply adjuvant therapy after exenteration in patients with positive margins and/or positive lymph nodes. However, adjuvant therapy is more frequently recommended in Germany (93%) than in the United States (74%). Conclusions: Our data reflect considerable differences about indications and contraindications, preoperative staging, and adjuvant therapy for pelvic exenteration between Germany and the United States.

KW - Chemoradiation

KW - Indication

KW - Palliative exenteration

KW - Pelvic exenteration

KW - Primary cervical cancer

KW - Recurrent cervical cancer

KW - Survey

UR - http://www.scopus.com/inward/record.url?scp=69349107489&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=69349107489&partnerID=8YFLogxK

U2 - 10.1111/IGC.0b013e3181a8351e

DO - 10.1111/IGC.0b013e3181a8351e

M3 - Article

VL - 19

SP - 974

EP - 977

JO - International Journal of Gynecological Cancer

JF - International Journal of Gynecological Cancer

SN - 1048-891X

IS - 5

ER -